Penumbra, Inc. (PEN) vs Smith & Nephew SNATS, Inc. (SNN)
- Penumbra, Inc. PEN 319.96 −0.36%
- Smith & Nephew SNATS, Inc. SNN 31.12 −2.78%
Penumbra, Inc. and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Penumbra, Inc. and Smith & Nephew SNATS, Inc. are of similar size ($13.4B and $12.7B). Smith & Nephew SNATS, Inc. trades at the lower P/E: 38.9× against 80.3×. Penumbra, Inc. grew revenue faster over the last twelve months: 17.0% against 4.81%. Penumbra, Inc. has the higher net margin (10.1% vs 6.71%) and the higher return on invested capital (12.7% vs 0.00%). Across the 22 metrics below, Penumbra, Inc. leads on 12 and Smith & Nephew SNATS, Inc. on 10.
Valuation
Profitability
| Metric | PEN | SNN | Medical Devices median |
|---|---|---|---|
| Gross margin | 67.98% | 70.52% | 57.76% |
| Operating margin | 12.13% | 0.00% | (15.07%) |
| Net margin | 10.06% | 6.71% | (14.45%) |
| Free cash flow margin | 12.84% | 0.00% | (3.88%) |
| Return on equity | 10.67% | 0.00% | (10.35%) |
| Return on assets | 8.33% | 0.00% | (17.26%) |
| Return on invested capital | 12.73% | 0.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack